Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44351 clinical trials with a EudraCT protocol, of which 7378 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (44,351)
Paediatric studies in scope of Art45 of the Paediatric Regulation (0)

44,351 result(s) found. Displaying page 2,114 of 2,218.

EudraCT Number: 2022-001088-29

Sponsor Protocol Number: CJDQ443B12201

Start Date*: 2022-10-26

Sponsor Name:Novartis Farmacéutica, S.A.

Full Title: KontRASt-06: An open-label phase II trial evaluating the activity and safety of JDQ443 single-agent as first-line treatment for patients with locally advanced or metastatic KRAS G12C-mutated non-sm...

Medical condition: locally advanced or metastatic KRAS G12C- mutated non-small cell lung cancer with a PD-L1 expression < 1% or a PD-L1 expression ≥ 1% and an STK11 co-mutation

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10061873	Non-small cell lung cancer	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Ongoing) HU (Trial now transitioned) FR (Trial now transitioned) DE (Trial now transitioned) IT (Trial now transitioned) BE (Trial now transitioned) BG (Completed) NL (Trial now transitioned) AT (Trial now transitioned) GR (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2019-001754-25	Sponsor Protocol Number: 371c	Start Date*: 2019-11-25
Sponsor Name:Reade
Full Title: Using adalimumab serum concentration to choose a subsequent biological treatment in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): an open label randomized superiority ...
Medical condition: rheumatoid arthritis
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: NL (Completed)
Trial results: (No results available)

EudraCT Number: 2018-004827-36

Sponsor Protocol Number: MOT-C-203

Start Date*: 2019-08-07

Sponsor Name:INOTREM S.A.

Full Title: Efficacy, Safety and Tolerability of Nangibotide in Patients with Septic Shock. A Randomized, Double-blind, Placebo Controlled Dose Selection Study.

Medical condition: Septic shock

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	23.1	10021881 - Infections and infestations	10040070	Septic shock	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed) FR (Completed) ES (Ongoing) DK (Completed) FI (Completed) IE (Completed)

Trial results: View results

EudraCT Number: 2019-001573-89

Sponsor Protocol Number: D8220C00008

Start Date*: 2019-09-24

Sponsor Name:AstraZeneca AB

Full Title: A Phase 3b, Multicenter, Open-Label, Single-Arm Study of Acalabrutinib (ACP-196) in Subjects with Chronic Lymphocytic Leukemia

Medical condition: Chronic lymphocytic leukemia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10008976	Chronic lymphocytic leukemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: NO (Trial now transitioned) GB (GB - no longer in EU/EEA) FI (Trial now transitioned) ES (Ongoing) FR (Trial now transitioned) DK (Trial now transitioned) NL (Trial now transitioned) IT (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2019-001576-11

Sponsor Protocol Number: 4010-03-001

Start Date*: 2019-09-10

Sponsor Name:TESARO, Inc.

Full Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) plus Carboplatin-paclitaxel versus Placebo Plus Carboplatin-paclitaxel in Patients with Recurrent or Primary Advanced...

Medical condition: Recurrent or primary advanced (Stage III or IV) endometrial cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10014740	Endometrial cancer stage III	PT
	21.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10014741	Endometrial cancer stage IV	PT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: HU (Trial now transitioned) DK (Trial now transitioned) NO (Trial now transitioned) PL (Trial now transitioned) FI (Trial now transitioned) DE (Trial now transitioned) BE (Trial now transitioned) NL (Trial now transitioned) GB (GB - no longer in EU/EEA) GR (Trial now transitioned) IT (Trial now transitioned) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2011-001492-39	Sponsor Protocol Number: DA2011	Start Date*: 2011-08-24
Sponsor Name:Vl-Medi Oy, Väestöliitto
Full Title: A randomized study to evaluate the predictive impact of using Cerazette progestin only pill before Nexplanon implant insertion regarding bleeding control
Medical condition: This study is a pilot study to test the effect of Cerazette minipill use before Nexplanon implant insertion to predict the bleeding pattern. The total subject number of 90, divided into two arms of...
Disease:
Population Age: Adults		Gender: Female
Trial protocol: FI (Completed)
Trial results: (No results available)

EudraCT Number: 2020-001957-31

Sponsor Protocol Number: KRKIPUNI

Start Date*: 2021-07-06

Sponsor Name:Eija Kalso

Full Title: Sleep and neuropathic pain: Sleep structure in neuropathic pain patients, psychological factors, brain connectivity, and the effects of pregabalin on sleep and pain

Medical condition: Neuropathic pain

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.0	100000004852	10054095	Neuropathic pain	LLT
	21.1	100000004852	10067547	Diabetic peripheral neuropathic pain	LLT
	20.0	100000004852	10077974	Peripheral neuropathic pain	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2021-004809-40

Sponsor Protocol Number: GV1001-AD-CL2-007

Start Date*: 2022-10-10

Sponsor Name:GemVax &KAEL Co., Ltd.

Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Prospective, 52-Week, Phase 2 Clinical Study to Evaluate the Safety and Efficacy of GV1001 Administered Subcutaneously ...

Medical condition: Mild to Moderate (stage 4 and 5) Alzheimer's Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	100000004852	10001896	Alzheimer's disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Temporarily Halted) FR (Trial now transitioned) PT (Trial now transitioned) IT (Trial now transitioned) FI (Trial now transitioned) NL (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2012-000810-12	Sponsor Protocol Number: IntReALL-HR-2010	Start Date*: Information not available in EudraCT
Sponsor Name:Charité - Universitätsmedizin Berlin
Full Title: IntReALL HR 2010 International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Medical condition: Acute lymphoblastic leukemia (ALL)
Disease:
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18		Gender: Male, Female
Trial protocol: SE (Ongoing) DE (Trial now transitioned) DK (Prematurely Ended) PT (Trial now transitioned) AT (Trial now transitioned) NO (Ongoing) FI (Trial now transitioned) FR (Trial now transitioned) CZ (Trial now transitioned) BE (Trial now transitioned) ES (Ongoing) IT (Trial now transitioned) NL (Trial now transitioned)
Trial results: (No results available)

EudraCT Number: 2011-001589-16	Sponsor Protocol Number: 344-13-03-02-2010	Start Date*: 2011-06-13
Sponsor Name:HUCH Eye Hospital
Full Title: MINOPTIC - A prospective, double-masked, placebo-controlled study on efficacy and safety of minicycline in the treatment of optic neuritis
Medical condition: optic neuritis
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: (No results available)

EudraCT Number: 2012-002678-29

Sponsor Protocol Number: BMS747158-302

Start Date*: 2013-02-21

Sponsor Name:Lantheus Medical Imaging, Inc.

Full Title: A Phase 3, Open-Label, Multicenter Study for the Assessment of Myocardial Perfusion using Positron Emission Tomography (PET) Imaging of Flurpiridaz F 18 Injection in Patients with Suspected or Know...

Medical condition: Assessment of myocardial perfusion using Positron Emission Tomography (PET) Imaging of Flurpiridaz F 18 Injection in patients with suspected or known coronary artery disease.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004849	10068617	Coronary heart disease	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Completed)

Trial results: (No results available)

EudraCT Number: 2012-005454-35

Sponsor Protocol Number: MG001

Start Date*: 2013-03-13

Sponsor Name:Hanna Pitkänen

Full Title: Can magnesium enhance blood coagulation amongst patients with alcohol induced liver cirrhosis?

Medical condition: Liver transplant candidates with alcohol induced liver cirrhosis and hypomagnesemia (P-Mg under 0,71 or magnesium substitution at least 750 mg/day)

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.1	100000004871	10024667	Liver cirrhosis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2015-005491-20	Sponsor Protocol Number: 20151205	Start Date*: 2016-08-29
Sponsor Name:Actavis Hungary Gyógyszermarketing és Kereskedelmi Korlátolt Felelősségű Társaság
Full Title: The effect of pancreatic enzyme replacement therapy on glucose metabolism, nutritional parameters, incretin response and beta-cell function in patients with diabetes mellitus and exocrine pancreati...
Medical condition: To study the patients with diabetes mellitus (type 1, 2 and 3c) and exocrine pancreatic insufficiency.
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: HU (Completed)
Trial results: (No results available)

EudraCT Number: 2018-000263-92

Sponsor Protocol Number: 17-251

Start Date*: 2018-05-28

Sponsor Name:CHU CAEN

Full Title: Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: a multicenter randomized, double-blind study

Medical condition: Patients > 18 years referred for elective cardiac bypass graft (CABG) surgery ± aortic valve replacement (AVR) without any systolic heart failure or any mitral surgery associated

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10007541 - Cardiac disorders	10003658	Atrial fibrillation	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Completed)

Trial results: (No results available)

EudraCT Number: 2013-005075-40	Sponsor Protocol Number: 2013-005075-40	Start Date*: 2014-04-08
Sponsor Name:Research Programs' Unit, Diabetes & Obesity, University of Helsinki
Full Title: The effect of Liraglutide treatment on postprandial chylomicron and VLDL kinetics, liver fat and de novo lipogenesis. A single-center randomized controlled study.
Medical condition: Type 2 diabetes
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: (No results available)

EudraCT Number: 2013-003727-11	Sponsor Protocol Number: 251176	Start Date*: 2014-02-26
Sponsor Name:Helsinki University Hospital, Department of Gastroenterology
Full Title: Randomised open-labelmulticenter study evaluating ciprofloxacin in severe alcoholic hepatitis in addition to prednisolon therapy
Medical condition: Alcoholic hepatitis
Disease:
Population Age: Adults		Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: (No results available)

EudraCT Number: 2014-001634-28

Sponsor Protocol Number: MDV3100-13(C3431004)

Start Date*: 2015-04-24

Sponsor Name:Medivation, Inc., a wholly owned subsidiary of Pfizer Inc.

Full Title: A Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men With High-Risk Nonmetastatic Prostate Cancer Progressi...

Medical condition: Patients with high-risk nonmetastatic prostate cancer progressing after definitive therapy (radical prostatectomy or radiotherapy or both).

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	20.0	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10060862	Prostate cancer	PT

Population Age: Adults, Elderly

Gender: Male

Trial protocol: SE (Trial now transitioned) FI (Trial now transitioned) AT (Trial now transitioned) NL (Trial now transitioned) ES (Ongoing) FR (Trial now transitioned) DK (Trial now transitioned) DE (Completed) SK (Trial now transitioned) IT (Trial now transitioned)

Trial results: (No results available)

EudraCT Number: 2015-000233-73	Sponsor Protocol Number: HCQvJan11	Start Date*: 2016-01-05
Sponsor Name:Helsinki University Central Hospital
Full Title: HYDROXYCHLOROQUINE IN ACUTE CORONARY SYNDROME: PREVENTION OF RECURRENT CARDIOVASCULAR EVENTS
Medical condition: Cardiovascular disease
Disease:
Population Age: Elderly		Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: (No results available)

EudraCT Number: 2015-000592-27	Sponsor Protocol Number: 13102014	Start Date*: 2015-06-18
Sponsor Name:Helsinki University Central Hospital
Full Title: Immunodeficiency in cartilage-hair hypoplasia: sub-project on safety of vaccination against chickenpox
Medical condition: Cartilage-hair hypoplasia patients.
Disease:
Population Age: Children, Adolescents, Under 18		Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: (No results available)

EudraCT Number: 2016-001938-96	Sponsor Protocol Number: PGLIT2016	Start Date*: 2016-12-22
Sponsor Name:Helsinki University Central Hospital
Full Title: Treatment of Giardia lamblia infections in children: randomized open-labeled trial comparing rectal metronidazole with oral tinidazole
Medical condition: Symptomatic Giardia lamblia infections in children
Disease:
Population Age: Infants and toddlers, Children, Under 18		Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: (No results available)

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Sat Jul 19 08:10:33 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA